Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Over the past few years, an approach emerged that combines different receptor-specific peptide radioligands able to bind different target structures on tumor cells concomitantly or separately. The reason for the growing interest in this special field of radiopharmaceutical development is rooted in the fact that bispecific peptide heterodimers can e...
Alternative Titles
Full title
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2611f8967a024c50aa6358d448bc0dcc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2611f8967a024c50aa6358d448bc0dcc
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph13080173
